-- Approximately 5,500 Autoimmune PAP Patients in the U.S. Identified in the Updated Analysis that Leveraged a More Recent and Comprehensive Claims Data Source -- -- New England Journal of Medicine ...

The refreshed analysis, conducted by a third-party advanced analytics provider, accessed a more current and comprehensive view of patient and healthcare claims data using open and closed source ...

Claim denials can be a huge headache for healthcare providers. In fact, one survey found that private payers initially deny 15 percent of medical claims. Worse? Providers end up spending almost $20 ...

(MENAFN- GlobeNewsWire - Nasdaq) Transforming Pharma Commercial Analytics with Advanced Patient Claims Data Analysis Pune, Feb. 29, 2024 (GLOBE NEWSWIRE) -- In an era where data is pivotal, the pharma ...

Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced an increased estimate of autoimmune PAP diagnosed ...